Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Acharaporn Duangjai, Kornkanok Ingkaninan & Nanteetip Limpeanchob. (2011) Potential mechanisms of hypocholesterolaemic effect of Thai spices/dietary extracts. Natural Product Research 25:4, pages 341-352.
Read now
Read now
Articles from other publishers (13)
Yujing Di, Zhaojun Wang, Chuandong Jia, Xin Xie, Shanshan Yang, Wenhua Wang, Xiaochuan Xie, Qian Wang, Chanyan Hu, Fang Xie, Mohamed Abdel-Moneim, Lionel Hovsepian, Yanzhen Wu, Na Yang & Jie Hou. (2023) A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly. Advances in Therapy 40:5, pages 2205-2216.
Crossref
Crossref
Frans Stellaard, Sabine Baumgartner, Ronald Mensink, Bjorn Winkens, Jogchum Plat & Dieter Lütjohann. (2022) Serum Low Density Lipoprotein Cholesterol Concentration Is Not Dependent on Cholesterol Synthesis and Absorption in Healthy Humans. Nutrients 14:24, pages 5370.
Crossref
Crossref
Sang Hyun Seo, Da Hyun Lee, Yu Seol Lee, Kyung Joo Cho, Hye Jung Park, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soo Han Bae & Seung Up Kim. (2022) Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model. Gastroenterology Report 10.
Crossref
Crossref
Tzu-Tsen Kuo, Yaw-Bin Huang & Ching-Jung Hsieh. (2020) Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study. BMJ Open 10:11, pages e036769.
Crossref
Crossref
P. R. Desai, P. J. Mehta, S. K. Ojha & A. B. Chokshi. (2018) Simultaneous quantification of related substances of ezetimibe and simvastatin in combined dosage form using a novel stability-indicating liquid chromatographic method. Acta Chromatographica 30:2, pages 85-94.
Crossref
Crossref
Acharaporn Duangjai, Nanteetip Limpeanchob, Kanittaporn Trisat & Doungporn Amornlerdpison. (2016) Spirogyra neglecta inhibits the absorption and synthesis of cholesterol in vitro. Integrative Medicine Research 5:4, pages 301-308.
Crossref
Crossref
Emilie Catry, Barbara D. Pachikian, Nuria Salazar, Audrey M. Neyrinck, Patrice D. Cani & Nathalie M. Delzenne. (2015) Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sciences 132, pages 77-84.
Crossref
Crossref
Na Li, Qing Li, Xia-Qiu Tian, Hai-Yan Qian & Yue-Jin Yang. (2014) Mipomersen is a Promising Therapy in the Management of Hypercholesterolemia: A Meta-Analysis of Randomized Controlled Trials. American Journal of Cardiovascular Drugs 14:5, pages 367-376.
Crossref
Crossref
C. Thomas CaskeyManuel L. Gonzalez-GarayStacey PereiraAmy L. McGuire. (2014) Adult Genetic Risk Screening. Annual Review of Medicine 65:1, pages 1-17.
Crossref
Crossref
Gregory S. Thomas, William C. Cromwell, Shariq Ali, Wai Chin, JoAnn D. Flaim & Michael Davidson. (2013) Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk. Journal of the American College of Cardiology 62:23, pages 2178-2184.
Crossref
Crossref
Giuseppe Danilo Norata, Christie M. Ballantyne & Alberico Luigi Catapano. (2013) New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. European Heart Journal 34:24, pages 1783-1789.
Crossref
Crossref
William C. Roberts, Antonio M. GottoJr.Jr., John Guyton, John LaRosa & Ronald Viggiani. (2011) The Editor's Roundtable: Closing the Clinical Practice Gap—Using Evidence-Based Treatments for Managing Lipids. The American Journal of Cardiology 107:2, pages 230-242.
Crossref
Crossref
Ke Li, Wenqi Yao, Xiudan Zheng & Kan Liao. (2009) Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Cell Research 19:8, pages 1006-1017.
Crossref
Crossref